Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Tax Provisions (2022 - 2025)

Historic Tax Provisions for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $250.0.

  • 60 Degrees Pharmaceuticals' Tax Provisions changed 0.0% to $250.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1312.0, marking a year-over-year increase of 6157.64%. This contributed to the annual value of $250.0 for FY2024, which is 0.0% changed from last year.
  • 60 Degrees Pharmaceuticals' Tax Provisions amounted to $250.0 in Q3 2025, which was down 0.0% from $1500.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Tax Provisions ranged from a high of $1500.0 in Q2 2025 and a low of -$501.0 during Q4 2024
  • Its 4-year average for Tax Provisions is $183.07, with a median of $63.0 in 2023.
  • Examining YoY changes over the last 5 years, 60 Degrees Pharmaceuticals' Tax Provisions showed a top increase of 59523.81% in 2024 and a maximum decrease of 92131.15% in 2024.
  • 60 Degrees Pharmaceuticals' Tax Provisions (Quarter) stood at -$250.0 in 2022, then surged by 124.4% to $61.0 in 2023, then tumbled by 921.31% to -$501.0 in 2024, then skyrocketed by 149.9% to $250.0 in 2025.
  • Its Tax Provisions was $250.0 in Q3 2025, compared to $1500.0 in Q2 2025 and $63.0 in Q1 2025.